February 9, 2021
Study: Lactobacillus Manipulates Bile Acids to Create Favorable Gut Environment
These findings further elucidate the complicated relationship between bile acids and gut bacteria and could eventually enable researchers to design lactobacilli with therapeutic properties.
January 21, 2021
Study: Inflamed Environment is C. diff Paradise
New CVM-led research shows that the inflammation caused by Clostridioides difficile infection gives the pathogen a two-fold advantage.
April 1, 2020
Drug Used to Treat Liver Disease Also Affects C. diff Life Cycle, Reduces Inflammation in Mice
The findings aid understanding of how the drug UDCA may be used in future treatment of C. diff infections in humans.
March 11, 2020
Study Shows CRISPR Effectiveness Against Colitis Pathogen
The study shows the system can be used to effectively target and eliminate the pathogen that causes the chronic, degenerative disease of the colon.
March 2, 2020
Theriot, Lanzas named University Faculty Scholars
The scholars program recognizes faculty for significant academic achievements and contributions to NC State.
July 7, 2019
CVM Researcher Awarded Grant for Innovative Disease Work
Matthew Foley has a singular focus: harnessing the body’s own power to fight off the devastating bacterium Clostridioides difficile. Now he’s getting invaluable help to reach his goal. Foley, a postdoctoral fellow at the NC State College of Veterinary Medicine, has received a prestigious National Institutes of Health T32 Training Grant to continue his promising
October 22, 2018
Grants Awarded to GI Research Projects at the CVM
Three NC State College of Veterinary Medicine researchers were awarded grants for digestive disease pilot studies at this month’s Center for Gastrointestinal Biology and Disease Research Day.
June 27, 2018
Compounds Kill C. diff, Don’t Affect Other Gut Bacteria In Vitro
NC State researchers developed a drug-testing pipeline to help identify compounds that worked against the three stages of Clostridium difficile infection, and found that a compound that holds promise for treating antibiotic-resistant bacteria may also be able to control C. difficile infections by killing the harmful bacteria without affecting other bacteria in the gut. Clostridium difficile, or C. diff, is a bacterium that
March 28, 2018
A Moveable Feast: Antibiotics Give C. diff a Nutrient-Rich Environment, No Competition
Antibiotic use creates a “banquet” for Clostridium difficile (C. diff), by altering the native gut bacteria that would normally compete with C. diff for nutrients...
April 2, 2017
Fighting Antibiotic-Resistant Bacteria in Food Animals
Responsible drug practices and antimicrobial resistance research is a CVM priority. The CVM includes faculty considered experts on such matters who shape the international conversation on approaches on drug use and antimicrobial resistance...